NCT03839238View on ClinicalTrials.gov

Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury

PHASE1UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 4, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

September 30, 2020

Conditions
Meniscus Injury
Interventions
BIOLOGICAL

hESC derived MSC like cell

Different dosage of hESC derived MSC like cell for the meniscus injured patients

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College of Science and Technology, Wuhan

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Tongji Hospital

OTHER

NCT03839238 - Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury | Biotech Hunter | Biotech Hunter